Title : Long Non-Coding RNA H19 Acts as an Estrogen Receptor Modulator that is Required for Endocrine Therapy Resistance in ER+ Breast Cancer Cells.

Pub. Date : 2018

PMID : 30497079






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: Here we report that treating ETR cells with Tam or Fulvestrant increases H19 expression and that it"s decreased expression overcomes resistance to Tam and Fulvestrant in these cells. Tamoxifen H19 imprinted maternally expressed transcript Homo sapiens
2 Interestingly, H19 expression is regulated by Notch and HGF signaling in the ETR cells and pharmacological inhibitors of Notch and c-MET signaling together significantly reverse resistance to Tam and Fulvestrant in an H19-dependent manner in these cells. Tamoxifen H19 imprinted maternally expressed transcript Homo sapiens